1 year return (CAGR)
87.47%
Global X Genomics & Biotechnology ETF Exchange (NASDAQ, USD)
GNOM
70.25
+2.49 (+3.67%)
NASDAQ
Loading...
3 year return (CAGR)
-
5 year return (CAGR)
-
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
-
Price/Sales
-
Ent value
-
Price/Book
-
Div yield
0.16%
Growth years
4
Div growth
-
FCF payout
-
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 67.33 |
| Daily high | 70.47 |
| Daily low | 67.33 |
| Daily Volume | 13K |
| All-time high | 70.25 |
| 1y analyst estimate | - |
| Beta | 1.63 |
| EPS (TTM) | - |
| Dividend per share | 0.12 |
| Ex-div date | 29 Jun 2026 |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| GNOM | S&P500 | |
| Current price drop from All-time high | -0.37% | -1.38% |
| Highest price drop | -75.01% | -56.47% |
| Date of highest drop | 8 Apr 2025 | 9 Mar 2009 |
| Avg drop from high | -31.62% | -10.68% |
| Avg time to new high | 11 days | 12 days |
| Max time to new high | 212 days | 1805 days |
News
